FDA comes down on Chinese API maker; India's Ind-Swift in talks with Teva, Perrigo;

> An FDA warning letter accuses Chinese API maker Zhejiang Jiuzhou Pharmaceutical of relabeling APIs to appear that it manufactured products it purchased from a supplier. Story

> Indian API maker Ind-Swift Lab is reportedly in talks with Teva ($TEVA) and Perrigo ($PRGO) to sell a stake of up to 30%. Report

> The FDA is backed up in approving applications for new generic products after receiving a surge of applications. Blog post

> Water system concerns are cropping up in some FDA warning letters. Report

And Finally... Freightwatch International reports that cargo thieves in two separate incidents recently tried to use jamming equipment to deter GPS tracking equipment on trucks of pharmaceuticals they had stolen. Report (sub. req.)